Erste Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Hold |
50,000
| – | – | 0.01% | 421 |
|
|
2025
Q1 | $1.71M | Hold |
50,000
| – | – | 0.02% | 325 |
|
|
2024
Q4 | $1.94M | Hold |
50,000
| – | – | 0.02% | 330 |
|
|
2024
Q3 | $1.93M | Hold |
50,000
| – | – | 0.02% | 327 |
|
|
2024
Q2 | $1.87M | Hold |
50,000
| – | – | 0.02% | 309 |
|
|
2024
Q1 | $2.15M | Hold |
50,000
| – | – | 0.03% | 294 |
|
|
2023
Q4 | $2.32M | Buy |
50,000
+15,000
| +43% | +$695K | 0.03% | 281 |
|
|
2023
Q3 | $1.24M | Hold |
35,000
| – | – | 0.02% | 323 |
|
|
2023
Q2 | $1.35M | Hold |
35,000
| – | – | 0.02% | 327 |
|
|
2023
Q1 | $1.25M | Hold |
35,000
| – | – | 0.02% | 330 |
|
|
2022
Q4 | $1.37M | Hold |
35,000
| – | – | 0.03% | 315 |
|
|
2022
Q3 | $1.26M | Hold |
35,000
| – | – | 0.03% | 326 |
|
|
2022
Q2 | $1.08M | Hold |
35,000
| – | – | 0.02% | 346 |
|
|
2022
Q1 | $1.05M | Hold |
35,000
| – | – | 0.02% | 349 |
|
|
2021
Q4 | $1.1M | Buy |
+35,000
| New | +$1.1M | 0.02% | 347 |
|